March 11, 2024 · Form 4 insider transaction
Foster Karen A. sold 319 shares of BioLife Solutions, Inc. at $17.42 per share, a transaction worth $5.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.